Skip to main content

Yusimry 40 mg/0.8 mL single-dose pen Images

Generic Name: adalimumab

This medication has been identified as Yusimry 40 mg/0.8 mL single-dose pen. It is supplied by Coherus BioSciences, Inc.

Yusimry is used in the treatment of Ankylosing Spondylitis; Crohn's Disease; Crohn's Disease, Active; Crohn's Disease, Maintenance; Hidradenitis Suppurativa and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Yusimry 40 mg/0.8 mL single-dose pen is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Yusimry 40 mg/0.8 mL single-dose pen medicine

Yusimry

Generic Name
adalimumab
Strength
40 mg/0.8 mL single-dose pen
Availability
Prescription only
Drug Class
TNF alfa inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Coherus BioSciences, Inc.
National Drug Code (NDC)
70114-0220

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.